These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28087950)

  • 21. Life cycle of yeast prions: propagation mediated by amyloid fibrils.
    Inoue Y
    Protein Pept Lett; 2009; 16(3):271-6. PubMed ID: 19275740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide sequences converting polyglutamine into a prion in yeast.
    Odani W; Urata K; Okuda M; Okuma S; Koyama H; Pack CG; Fujiwara K; Nojima T; Kinjo M; Kawai-Noma S; Taguchi H
    FEBS J; 2015 Feb; 282(3):477-90. PubMed ID: 25406629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the yeast prion world: Active prion conversion of non-glutamine/asparagine-rich Mod5 for cell survival.
    Suzuki G; Tanaka M
    Prion; 2013; 7(2):109-13. PubMed ID: 23117914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and molecular basis of cross-seeding barriers in amyloids.
    Daskalov A; Martinez D; Coustou V; El Mammeri N; Berbon M; Andreas LB; Bardiaux B; Stanek J; Noubhani A; Kauffmann B; Wall JS; Pintacuda G; Saupe SJ; Habenstein B; Loquet A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of prion transmission barriers by mutational control of amyloid conformations.
    Chien P; DePace AH; Collins SR; Weissman JS
    Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers.
    DePace AH; Weissman JS
    Nat Struct Biol; 2002 May; 9(5):389-96. PubMed ID: 11938354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinase K resistant cores of prions and amyloids.
    Kushnirov VV; Dergalev AA; Alexandrov AI
    Prion; 2020 Dec; 14(1):11-19. PubMed ID: 31876447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for the in vivo and in vitro analysis of [Het-s] prion infectivity.
    Benkemoun L; Sabaté R; Malato L; Dos Reis S; Dalstra H; Saupe SJ; Maddelein ML
    Methods; 2006 May; 39(1):61-7. PubMed ID: 16750391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What makes a protein sequence a prion?
    Sabate R; Rousseau F; Schymkowitz J; Ventura S
    PLoS Comput Biol; 2015 Jan; 11(1):e1004013. PubMed ID: 25569335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion.
    DePace AH; Santoso A; Hillner P; Weissman JS
    Cell; 1998 Jun; 93(7):1241-52. PubMed ID: 9657156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery.
    Chernova TA; Chernoff YO; Wilkinson KD
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are prions part of the dark matter of the cell?
    Baudin-Baillieu A; Fabret C; Namy O
    Prion; 2011; 5(4):299-304. PubMed ID: 22052346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloidogenic domains, prions and structural inheritance: rudiments of early life or recent acquisition?
    Chernoff YO
    Curr Opin Chem Biol; 2004 Dec; 8(6):665-71. PubMed ID: 15556413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast.
    Alberti S; Halfmann R; Lindquist S
    Methods Enzymol; 2010; 470():709-34. PubMed ID: 20946833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The [Het-s] prion, an amyloid fold as a cell death activation trigger.
    Saupe SJ; Daskalov A
    PLoS Pathog; 2012; 8(5):e1002687. PubMed ID: 22654661
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging principles of conformation-based prion inheritance.
    Chien P; Weissman JS; DePace AH
    Annu Rev Biochem; 2004; 73():617-56. PubMed ID: 15189155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-propagating amyloid as a critical regulator for diverse cellular functions.
    Sugiyama S; Tanaka M
    J Biochem; 2014 Jun; 155(6):345-51. PubMed ID: 24711463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+].
    Patel BK; Liebman SW
    J Mol Biol; 2007 Jan; 365(3):773-82. PubMed ID: 17097676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.